H.U. Group Holdings, Inc. Share Price

Equities

4544

JP3822000000

Healthcare Facilities & Services

Market Closed - Japan Exchange 07:00:00 26/04/2024 BST 5-day change 1st Jan Change
2,416 JPY +0.86% Intraday chart for H.U. Group Holdings, Inc. +3.85% -9.29%

Financials

Sales 2024 * 237B 1.5B 120B Sales 2025 * 246B 1.55B 124B Capitalization 137B 867M 69.4B
Net income 2024 * 379M 2.39M 192M Net income 2025 * 5.6B 35.32M 2.83B EV / Sales 2024 * 0.74 x
Net Debt 2024 * 37.1B 234M 18.76B Net Debt 2025 * 34.76B 219M 17.57B EV / Sales 2025 * 0.7 x
P/E ratio 2024 *
364 x
P/E ratio 2025 *
24.6 x
Employees 5,437
Yield 2024 *
5.17%
Yield 2025 *
5.18%
Free-Float 98.83%
More Fundamentals * Assessed data
Dynamic Chart
H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Executive Officer CI
H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Chief Financial Officer CI
H.U Unit Fujirebio Diagnostics Partners Beckman Coulter in Neurodegenerative Diseases Field MT
Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics CI
H.U. Group Holdings Inc. and Fujirebio Announces the Availability of the Lumipulse G pTau 217 Plasma Assay for the Fully Automated LUMIPULSE G Immunoassay Systems CI
Japanese Shares Rebound After Inflation Data, BoJ Rate Outlook MT
H.U. Group to Issue Stock Options to Directors, Employees MT
H.U. Group to Grant Share Options to Staff MT
H.U. Group Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index CI
H.U. Group Holdings' Fiscal Full-Year Profit Falls 47% MT
H.U. Group Holdings, Inc. Announces Dividend for the Year Ended March 31, 2023, Payable on May 30, 2023; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024 CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2024 CI
H.U. Group Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
H.U. Group Holdings, Inc. Announces Launch of the Fully Automated Lumipulse® G NfL CSF and Lumipulse® G NfL Blood tests CI
More news
1 day+0.86%
1 week+3.85%
Current month-1.11%
1 month-5.62%
3 months-10.67%
6 months-1.67%
Current year-9.29%
More quotes
1 week
2 341.00
Extreme 2341
2 425.50
1 month
2 321.00
Extreme 2321
2 506.50
Current year
2 321.00
Extreme 2321
2 841.50
1 year
2 321.00
Extreme 2321
2 863.00
3 years
2 321.00
Extreme 2321
3 740.00
5 years
2 005.00
Extreme 2005
3 770.00
10 years
2 005.00
Extreme 2005
6 350.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 31/05/16
Director of Finance/CFO 65 30/06/20
Chief Tech/Sci/R&D Officer 68 22/06/21
Members of the board TitleAgeSince
Chief Executive Officer 70 31/05/16
Director/Board Member 53 31/08/11
Director/Board Member 77 31/05/18
More insiders
Date Price Change Volume
26/04/24 2,416 +0.86% 238,500
25/04/24 2,396 -0.44% 164,300
24/04/24 2,406 +0.38% 237,700
23/04/24 2,397 +0.31% 296,300
22/04/24 2,390 +2.71% 259,900

Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am

More quotes
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
5
Last Close Price
2,416 JPY
Average target price
2,582 JPY
Spread / Average Target
+6.87%
Consensus